Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17037
Country/Region: South Africa
Year: 2017
Main Partner: University of the Witwatersrand
Main Partner Program: Wits Reproductive Health and HIV Institute
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $7,401,625 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,225,379
Care: TB/HIV (HVTB) $1,006,555
Care: Pediatric Care and Support (PDCS) $268,027
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $536,055
Treatment: Adult Treatment (HTXS) $4,097,582
Treatment: Pediatric Treatment (PDTX) $268,027
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 211,912
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 23,544
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 100
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 949
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 58
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 486
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 13
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 107
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 12
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 107
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2018 188
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 109
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 958
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 22
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 204
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 22
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 204
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 15
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 192
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 129
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 122
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 1,595
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 83
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 1,064
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 916
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 11,473
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 614
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 7,649
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 74
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 964
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 50
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 642
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 331
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 2,949
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 3
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 25
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 17
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 20
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 171
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 13
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 112
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 15
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 8
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 7
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 57
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 29
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 38
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 20
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 406
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 213
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 271
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 141
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 34
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 18
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 22
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 12
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 1,697
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 110
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 110
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 200
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 200
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 9,834
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 6,560
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 76
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 55
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 279
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 186
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 976
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 976
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 1,828
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 1,728
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 88,521
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 59,016
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 679
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 455
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 2,510
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 1,673
HTS_TST Sum of Test Result disaggregates 2018 2,348
HTS_TST Sum of Test Result disaggregates 2018 21,007
HTS_TST_POS By Test Result: Positive 2018 2,348
HTS_TST_POS By Test Result: Positive 2018 21,007
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 105
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 54
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 188
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 111
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 177
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 117
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 98
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 1,275
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 66
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 852
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 111
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 70
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 327
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 45
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,094
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 728
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 109
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 109
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 200
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 200
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 9,832
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 6,556
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 77
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 55
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 279
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 184
PMTCT_ART Already on ART at beginning of current pregnancy 2018 337
PMTCT_ART Already on ART at beginning of current pregnancy 2018 3,077
PMTCT_ART New on ART 2018 492
PMTCT_ART New on ART 2018 4,405
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 829
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 7,482
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,986
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 26,863
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 954
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 6,986
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 762
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,722
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 148
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 4,983
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 31
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 11
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 13
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 270
PMTCT_STAT By Age (Numerator): : 15-19 2018 35
PMTCT_STAT By Age (Numerator): 15-19 2018 316
PMTCT_STAT By Age (Numerator): 20-24 2018 71
PMTCT_STAT By Age (Numerator): 20-24 2018 628
PMTCT_STAT By Age (Numerator): 25-49 2018 2,880
PMTCT_STAT By Age (Numerator): 25-49 2018 25,919
PMTCT_STAT By known positives: 15-19 2018 4
PMTCT_STAT By known positives: 20-24 2018 9
PMTCT_STAT By known positives: 25-49 2018 394
PMTCT_STAT By new negatives: 15-19 2018 26
PMTCT_STAT By new negatives: 20-24 2018 51
PMTCT_STAT By new negatives: 25-49 2018 2,071
PMTCT_STAT By new positives: 15-19 2018 5
PMTCT_STAT By new positives: 20-24 2018 11
PMTCT_STAT By new positives: 25-49 2018 415
PMTCT_STAT By Number of known positives: 15-19 2018 38
PMTCT_STAT By Number of known positives: 20-24 2018 73
PMTCT_STAT By Number of known positives: 25-49 2018 3,547
PMTCT_STAT By Number of new negative: 15-19 2018 242
PMTCT_STAT By Number of new negative: 20-24 2018 483
PMTCT_STAT By Number of new negative: 25-49 2018 18,605
PMTCT_STAT By Number of new positives: 15-19 2018 38
PMTCT_STAT By Number of new positives: 20-24 2018 73
PMTCT_STAT By Number of new positives: 25-49 2018 3,764
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,986
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 26,863
PMTCT_STAT_den By Age (Denominator): <15-19 2018 332
PMTCT_STAT_den By Age (Denominator): 15-19 2018 35
PMTCT_STAT_den By Age (Denominator): 20-24 2018 71
PMTCT_STAT_den By Age (Denominator): 20-24 2018 674
PMTCT_STAT_den By Age (Denominator): 25-49 2018 2,939
PMTCT_STAT_den By Age (Denominator): 25-49 2018 27,611
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 135
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 862
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,160
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 9,013
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 135
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 860
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 674
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 6,133
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 2,281
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 18,690
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 2,103
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 16,868
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 150
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 943
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,244
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 9,717
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 150
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 942
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 738
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 7,088
TB_PREV By Age/Sex (Numerator): <15, Female 2018 6
TB_PREV By Age/Sex (Numerator): <15, Female 2018 88
TB_PREV By Age/Sex (Numerator): <15, Male 2018 4
TB_PREV By Age/Sex (Numerator): <15, Male 2018 52
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 314
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 2,687
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 198
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,678
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 522
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 4,505
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 522
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 4,505
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 1,008
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 8,879
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 11
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 162
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 4
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 78
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 594
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 5,170
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 399
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 3,469
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 1,008
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 8,879
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 146
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 738
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,362
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 8,021
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 136
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 740
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 913
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 5,543
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,558
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 15,042
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,789
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 15,200
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 157
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 763
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,486
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 8,078
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 147
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 761
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 999
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 5,598
TX_CURR Age/Sex: <1 2018 6
TX_CURR Age/Sex: <1 2018 89
TX_CURR Age/Sex: <1-9 2018 795
TX_CURR Age/Sex: 1-9 2018 17
TX_CURR Age/Sex: 10-14 Female 2018 18
TX_CURR Age/Sex: 10-14 Female 2018 354
TX_CURR Age/Sex: 10-14 Male 2018 13
TX_CURR Age/Sex: 10-14 Male 2018 330
TX_CURR Age/Sex: 15-19 Female 2018 40
TX_CURR Age/Sex: 15-19 Female 2018 494
TX_CURR Age/Sex: 15-19 Male 2018 13
TX_CURR Age/Sex: 15-19 Male 2018 337
TX_CURR Age/Sex: 20-24 Female 2018 193
TX_CURR Age/Sex: 20-24 Female 2018 2,579
TX_CURR Age/Sex: 20-24 Male 2018 34
TX_CURR Age/Sex: 20-24 Male 2018 651
TX_CURR Age/Sex: 25-49 Female 2018 5,489
TX_CURR Age/Sex: 25-49 Female 2018 45,460
TX_CURR Age/Sex: 25-49 Male 2018 2,247
TX_CURR Age/Sex: 25-49 Male 2018 24,412
TX_CURR Age/Sex: 50+ Female 2018 871
TX_CURR Age/Sex: 50+ Female 2018 4,508
TX_CURR Age/Sex: 50+ Male 2018 321
TX_CURR Age/Sex: 50+ Male 2018 3,346
TX_CURR Aggregated Age/Sex: <15 Female 2018 140
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,098
TX_CURR Aggregated Age/Sex: <15 Male 2018 129
TX_CURR Aggregated Age/Sex: <15 Male 2018 994
TX_CURR Aggregated Age/Sex: 15+ Female 2018 5,025
TX_CURR Aggregated Age/Sex: 15+ Female 2018 44,706
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,104
TX_CURR Aggregated Age/Sex: 15+ Male 2018 19,785
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 16,660
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 149,938
TX_CURR Sum of age/sex disaggregates 2018 831
TX_CURR Sum of Age/Sex disaggregations 2018 53
TX_CURR Sum of Aggregated Age/Sex <15 2018 269
TX_CURR Sum of Aggregated Age/Sex <15 2018 2,092
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 7,129
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 64,491
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 7,398
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 66,583
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 176
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 21
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 143
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 909
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 7,975
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 402
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 3,889
TX_NEW By Age/Sex: <1 2018 103
TX_NEW By Age/Sex: <1 2018 6
TX_NEW By Age/Sex: 1-9 2018 91
TX_NEW By Age/Sex: 1-9 2018 5
TX_NEW By Age/Sex: 10-14 Female 2018 6
TX_NEW By Age/Sex: 10-14 Female 2018 59
TX_NEW By Age/Sex: 10-14 Male 2018 47
TX_NEW By Age/Sex: 10-14 Male 2018 5
TX_NEW By Age/Sex: 15-19 Female 2018 13
TX_NEW By Age/Sex: 15-19 Female 2018 158
TX_NEW By Age/Sex: 15-19 Male 2018 35
TX_NEW By Age/Sex: 15-19 Male 2018 4
TX_NEW By Age/Sex: 20-24 Female 2018 73
TX_NEW By Age/Sex: 20-24 Female 2018 941
TX_NEW By Age/Sex: 20-24 Male 2018 190
TX_NEW By Age/Sex: 20-24 Male 2018 11
TX_NEW By Age/Sex: 25-49 Female 2018 538
TX_NEW By Age/Sex: 25-49 Female 2018 4,537
TX_NEW By Age/Sex: 25-49 Male 2018 2,252
TX_NEW By Age/Sex: 25-49 Male 2018 235
TX_NEW By Age/Sex: 50+ Female 2018 56
TX_NEW By Age/Sex: 50+ Female 2018 308
TX_NEW By Age/Sex: 50+ Male 2018 43
TX_NEW By Age/Sex: 50+ Male 2018 233
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 21,137
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 2,350
TX_NEW Sum of Age/Sex disaggregates 2018 984
TX_NEW Sum of Age/Sex disaggregates 2018 8,760
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 1,355
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 12,183
TX_PVLS <15, Undocumented Test Indication, Female 2018 130
TX_PVLS <15, Undocumented Test Indication, Female 2018 162
TX_PVLS <15, Undocumented Test Indication, Female 2018 1,843
TX_PVLS <15, Undocumented Test Indication, Female 2018 2,261
TX_PVLS <15, Undocumented Test Indication, Male 2018 106
TX_PVLS <15, Undocumented Test Indication, Male 2018 158
TX_PVLS <15, Undocumented Test Indication, Male 2018 1,745
TX_PVLS <15, Undocumented Test Indication, Male 2018 2,159
TX_PVLS 15+, Undocumented Test Indication, Female 2018 10,092
TX_PVLS 15+, Undocumented Test Indication, Female 2018 11,060
TX_PVLS 15+, Undocumented Test Indication, Female 2018 82,771
TX_PVLS 15+, Undocumented Test Indication, Female 2018 90,860
TX_PVLS 15+, Undocumented Test Indication, Male 2018 3,609
TX_PVLS 15+, Undocumented Test Indication, Male 2018 4,106
TX_PVLS 15+, Undocumented Test Indication, Male 2018 39,075
TX_PVLS 15+, Undocumented Test Indication, Male 2018 44,092
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 15,486
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 139,372
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 13,937
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 125,434
TX_PVLS Undocumented Test Indication 2018 13,937
TX_PVLS Undocumented Test Indication 2018 15,486
TX_PVLS Undocumented Test Indication 2018 125,434
TX_PVLS Undocumented Test Indication 2018 139,372
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 12
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 305
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 7
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 304
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,276
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 17,892
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 767
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,070
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,062
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 27,571
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 3,405
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 30,652
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 12
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 350
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 8
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 342
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,528
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 20,062
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 857
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 9,898
Cross Cutting Budget Categories and Known Amounts Total: $1,617,280
Gender: Gender Equality $124,731
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Condoms: Policy, Tools, and Services $81,709
Human Resources for Health $1,355,826
Food and Nutrition: Policy, Tools, and Service Delivery $55,014